Cargando…
Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans
BACKGROUND: Limited real‐world data exist on healthcare resource utilization (HCRU) and associated costs of patients with heart failure (HF) with reduced ejection fraction (HFrEF) and preserved EF (HFpEF), including urgent HF visits, which are assumed to be less burdensome than HF hospitalizations (...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wiley Periodicals, Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119853/ https://www.ncbi.nlm.nih.gov/pubmed/33704817 http://dx.doi.org/10.1002/clc.23585 |
_version_ | 1783691942146605056 |
---|---|
author | Lam, Carolyn S. P. Wood, Robert Vaduganathan, Muthiah Bueno, Hector Chin, Alex Luporini Saraiva, Gabriela Sörstadius, Elisabeth Tritton, Theo Thomas, Joseph Qin, Lei |
author_facet | Lam, Carolyn S. P. Wood, Robert Vaduganathan, Muthiah Bueno, Hector Chin, Alex Luporini Saraiva, Gabriela Sörstadius, Elisabeth Tritton, Theo Thomas, Joseph Qin, Lei |
author_sort | Lam, Carolyn S. P. |
collection | PubMed |
description | BACKGROUND: Limited real‐world data exist on healthcare resource utilization (HCRU) and associated costs of patients with heart failure (HF) with reduced ejection fraction (HFrEF) and preserved EF (HFpEF), including urgent HF visits, which are assumed to be less burdensome than HF hospitalizations (hHFs) HYPOTHESIS: This study aimed to quantify the economic burden of HFrEF and HFpEF, via a retrospective, longitudinal cohort study, using IBM® linked claims/electronic health records (Commercial and Medicare Supplemental data only). METHODS: Adult patients, indexed on HF diagnosis (ICD‐10‐CM: I50.x) from July 2012 through June 2018, with 6‐month minimum baseline period and varying follow‐up, were classified as HFrEF (I50.2x) or HFpEF (I50.3x) according to last‐observed EF‐specific diagnosis. HCRU/costs were assessed during follow‐up. RESULTS: About 109 721 HF patients (22% HFrEF, 31% HFpEF, 47% unclassified EF; median 18 months' follow‐up) were identified. There were 3.2 all‐cause outpatient visits per patient‐month (HFrEF, 3.3; HFpEF, 3.6); 69% of patients required inpatient stays (HFrEF, 80%; HFpEF, 78%). Overall, 11% of patients experienced hHFs (HFrEF, 23%; HFpEF, 16%), 9% experienced urgent HF visits (HFrEF, 15%; HFpEF, 12%); 26% were hospitalized less than 30 days after first urgent HF visit versus 11% after first hHF. Mean monthly total direct healthcare cost per patient was $9290 (HFrEF, $11 053; HFpEF, $7482). CONCLUSIONS: HF‐related HCRU is substantial among contemporary real‐world HF patients in US Commercial or Medicare supplemental health plans. Patients managed in urgent HF settings were over twice as likely to be hospitalized within 30 days versus those initially hospitalized, suggesting urgent HF visits are important clinical events and quality improvement targets. |
format | Online Article Text |
id | pubmed-8119853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Wiley Periodicals, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-81198532021-05-20 Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans Lam, Carolyn S. P. Wood, Robert Vaduganathan, Muthiah Bueno, Hector Chin, Alex Luporini Saraiva, Gabriela Sörstadius, Elisabeth Tritton, Theo Thomas, Joseph Qin, Lei Clin Cardiol Clinical Investigations BACKGROUND: Limited real‐world data exist on healthcare resource utilization (HCRU) and associated costs of patients with heart failure (HF) with reduced ejection fraction (HFrEF) and preserved EF (HFpEF), including urgent HF visits, which are assumed to be less burdensome than HF hospitalizations (hHFs) HYPOTHESIS: This study aimed to quantify the economic burden of HFrEF and HFpEF, via a retrospective, longitudinal cohort study, using IBM® linked claims/electronic health records (Commercial and Medicare Supplemental data only). METHODS: Adult patients, indexed on HF diagnosis (ICD‐10‐CM: I50.x) from July 2012 through June 2018, with 6‐month minimum baseline period and varying follow‐up, were classified as HFrEF (I50.2x) or HFpEF (I50.3x) according to last‐observed EF‐specific diagnosis. HCRU/costs were assessed during follow‐up. RESULTS: About 109 721 HF patients (22% HFrEF, 31% HFpEF, 47% unclassified EF; median 18 months' follow‐up) were identified. There were 3.2 all‐cause outpatient visits per patient‐month (HFrEF, 3.3; HFpEF, 3.6); 69% of patients required inpatient stays (HFrEF, 80%; HFpEF, 78%). Overall, 11% of patients experienced hHFs (HFrEF, 23%; HFpEF, 16%), 9% experienced urgent HF visits (HFrEF, 15%; HFpEF, 12%); 26% were hospitalized less than 30 days after first urgent HF visit versus 11% after first hHF. Mean monthly total direct healthcare cost per patient was $9290 (HFrEF, $11 053; HFpEF, $7482). CONCLUSIONS: HF‐related HCRU is substantial among contemporary real‐world HF patients in US Commercial or Medicare supplemental health plans. Patients managed in urgent HF settings were over twice as likely to be hospitalized within 30 days versus those initially hospitalized, suggesting urgent HF visits are important clinical events and quality improvement targets. Wiley Periodicals, Inc. 2021-03-11 /pmc/articles/PMC8119853/ /pubmed/33704817 http://dx.doi.org/10.1002/clc.23585 Text en © 2021 The Authors. Clinical Cardiology published by Wiley Periodicals LLC. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Clinical Investigations Lam, Carolyn S. P. Wood, Robert Vaduganathan, Muthiah Bueno, Hector Chin, Alex Luporini Saraiva, Gabriela Sörstadius, Elisabeth Tritton, Theo Thomas, Joseph Qin, Lei Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans |
title | Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans |
title_full | Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans |
title_fullStr | Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans |
title_full_unstemmed | Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans |
title_short | Contemporary economic burden in a real‐world heart failure population with Commercial and Medicare supplemental plans |
title_sort | contemporary economic burden in a real‐world heart failure population with commercial and medicare supplemental plans |
topic | Clinical Investigations |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8119853/ https://www.ncbi.nlm.nih.gov/pubmed/33704817 http://dx.doi.org/10.1002/clc.23585 |
work_keys_str_mv | AT lamcarolynsp contemporaryeconomicburdeninarealworldheartfailurepopulationwithcommercialandmedicaresupplementalplans AT woodrobert contemporaryeconomicburdeninarealworldheartfailurepopulationwithcommercialandmedicaresupplementalplans AT vaduganathanmuthiah contemporaryeconomicburdeninarealworldheartfailurepopulationwithcommercialandmedicaresupplementalplans AT buenohector contemporaryeconomicburdeninarealworldheartfailurepopulationwithcommercialandmedicaresupplementalplans AT chinalex contemporaryeconomicburdeninarealworldheartfailurepopulationwithcommercialandmedicaresupplementalplans AT luporinisaraivagabriela contemporaryeconomicburdeninarealworldheartfailurepopulationwithcommercialandmedicaresupplementalplans AT sorstadiuselisabeth contemporaryeconomicburdeninarealworldheartfailurepopulationwithcommercialandmedicaresupplementalplans AT trittontheo contemporaryeconomicburdeninarealworldheartfailurepopulationwithcommercialandmedicaresupplementalplans AT thomasjoseph contemporaryeconomicburdeninarealworldheartfailurepopulationwithcommercialandmedicaresupplementalplans AT qinlei contemporaryeconomicburdeninarealworldheartfailurepopulationwithcommercialandmedicaresupplementalplans |